Korsana Biosciences, Inc. (KRSA)
31.31
-2.12
(-6.34%)
USD |
NASDAQ |
Oct 23, 16:00
31.44
+0.14
(+0.43%)
After-Hours: 20:00
Korsana Biosciences Market Cap : 19.04M for Oct. 23, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 23, 2026 | 19.04M |
| October 22, 2026 | 20.33M |
| October 21, 2026 | 19.78M |
| October 20, 2026 | 18.87M |
| October 19, 2026 | 19.10M |
| October 16, 2026 | 19.69M |
| October 15, 2026 | 20.46M |
| October 14, 2026 | 20.87M |
| October 13, 2026 | 19.25M |
| October 12, 2026 | 20.70M |
| October 09, 2026 | 20.62M |
| October 08, 2026 | 20.37M |
| October 07, 2026 | 19.24M |
| October 06, 2026 | 19.32M |
| October 05, 2026 | 18.68M |
| October 02, 2026 | 18.54M |
| October 01, 2026 | 18.97M |
| September 30, 2026 | 19.46M |
| September 29, 2026 | 20.67M |
| September 28, 2026 | 18.74M |
| September 25, 2026 | 18.85M |
| September 24, 2026 | 22.61M |
| September 23, 2026 | 19.64M |
| September 22, 2026 | 21.27M |
| September 21, 2026 | 20.19M |
| Date | Value |
|---|---|
| September 18, 2026 | 21.27M |
| September 17, 2026 | 20.50M |
| September 16, 2026 | 18.99M |
| September 15, 2026 | 19.50M |
| September 14, 2026 | 19.22M |
| September 11, 2026 | 19.40M |
| September 10, 2026 | 14.93M |
| September 09, 2026 | 15.93M |
| September 08, 2026 | 14.30M |
| September 04, 2026 | 18.09M |
| September 03, 2026 | 147.78M |
| September 02, 2026 | 134.67M |
| September 01, 2026 | 124.24M |
| August 31, 2026 | 109.64M |
| August 28, 2026 | 112.92M |
| August 27, 2026 | 118.88M |
| August 26, 2026 | 123.65M |
| August 25, 2026 | 119.18M |
| August 24, 2026 | 117.09M |
| August 21, 2026 | 115.90M |
| August 20, 2026 | 121.26M |
| August 19, 2026 | 123.05M |
| August 18, 2026 | 122.75M |
| August 17, 2026 | 120.07M |
| August 14, 2026 | 112.92M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Climb Bio, Inc. | 585.28M |
| Q32 Bio, Inc. | 205.32M |
| Arrowhead Pharmaceuticals, Inc. | 8.189B |
| Oncolytics Biotech, Inc. | 62.61M |
| Sangamo Therapeutics, Inc. | 47.64M |
Market Cap Related Metrics
| PS Ratio | 9.124 |
| PEG Ratio | -0.0211 |
| Price to Book Value | 3.742 |
| Price | 31.31 |
| Earnings Yield | -37.56% |
| PEGY Ratio | -0.0211 |